Knowledge, attitude, and practice toward mucormycosis among patients presenting to six tertiary eye care hospitals in South India - A multicentric online questionnaire-based survey.


Journal

Indian journal of ophthalmology
ISSN: 1998-3689
Titre abrégé: Indian J Ophthalmol
Pays: India
ID NLM: 0405376

Informations de publication

Date de publication:
06 2022
Historique:
entrez: 1 6 2022
pubmed: 2 6 2022
medline: 7 6 2022
Statut: ppublish

Résumé

To study the awareness on mucormycosis among outpatients who visited six tertiary eye care hospitals at Madurai, Pondicherry, Coimbatore, Tirunelveli, Chennai, and Tirupati. This was a telephone-based survey conducted using questionnaires consisting of 38 questions in five sections from July 5 to 25, 2021. Patients visiting the eye hospitals for an examination were contacted over their phones and responses were directly entered onto the Google forms platform. A total of 4573 participants were included in the study. Among all participants, a cumulative 83% of participants had some knowledge of mucormycosis. More than 80% of them reported that their prime source of information was through mass communication like television or radio. Around 34.8% of the respondents were aware that it can occur after treatment for coronavirus disease 2019 (COVID-19) infection, only half of them (54.3%) knew that systemic steroids were the main risk factor. The knowledge scores were higher for participants who were diabetics (n = 1235) or had been affected by COVID-19 earlier (n = 456) or whose friends had mucormycosis earlier (n = 312). Knowledge, attitude, and practice (KAP) scores of nonprofessional health-care workers (n = 103) were much better compared to patients. Such KAP studies give us an idea of the impact of the measures taken for educating the public. In this study, a cumulative 83% of participants had some knowledge of mucormycosis and 86% knew that this was an emergency. More than 50% of the participants were not aware that diabetes is a risk factor for mucormycosis.

Identifiants

pubmed: 35648003
pii: IndianJOphthalmol_2022_70_6_2158_346109
doi: 10.4103/ijo.IJO_103_22
pmc: PMC9359275
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2158-2162

Déclaration de conflit d'intérêts

None

Références

Front Public Health. 2021 Nov 26;9:787845
pubmed: 34900923
Lancet. 2020 Feb 22;395(10224):565-574
pubmed: 32007145
Postgrad Med J. 2004 Nov;80(949):670-4
pubmed: 15537854
Orbit. 2022 Feb 22;:1-12
pubmed: 35192435
Rural Remote Health. 2018 Feb;18(1):4304
pubmed: 29458256
Indian J Ophthalmol. 2021 Feb;69(2):244-252
pubmed: 33463566
Z Gesundh Wiss. 2022;30(7):1661-1673
pubmed: 34007782
JAMA. 2020 Mar 17;323(11):1039-1040
pubmed: 32022836
JAMA. 2020 May 12;323(18):1775-1776
pubmed: 32203977
Ophthalmic Plast Reconstr Surg. 2021 Sep-Oct 01;37(5):488-495
pubmed: 34314399
Travel Med Infect Dis. 2021 Nov-Dec;44:102148
pubmed: 34454090
Indian J Ophthalmol. 2021 Jul;69(7):1670-1692
pubmed: 34156034

Auteurs

Rajagopalan Jayagayathri (R)

Department of Orbit and Oculoplasty, Aravind Eye Hospital, Pondicherry, India.

Preeti Mohanty (P)

Department of Orbit and Oculoplasty, Aravind Eye Hospital, Tirupati, Andhra Pradesh, India.

Dayakar Yadalla (D)

Department of Orbit and Oculoplasty, Aravind Eye Hospital, Pondicherry, India.

Jayashree Bakthavatchalam (J)

Department of Orbit and Oculoplasty, Aravind Eye Hospital, Chennai, Tamil Nadu, India.

Viji Rangarajan (V)

Department of Orbit and Oculoplasty, Aravind Eye Hospital, Coimbatore, Tamil Nadu, India.

Velu Maneksha (V)

Department of Orbit and Oculoplasty, Aravind Eye Hospital, Tirunelveli, Tamil Nadu, India.

Meghana Tanwar (M)

Department of Orbit and Oculoplasty, Aravind Eye Hospital, Madurai, Tamil Nadu, India.

Rengaraj Venkatesh (R)

Chief Medical Officer, Department of Glaucoma, Aravind Eye Hospital, Pondicherry, India.

Sivagnanam Jayashree (S)

Project Manager, Aravind Eye Hospital, Pondicherry, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH